Terms: = Head and neck cancer AND SRGAP3, MEGAP, 9901, ENSG00000196220, ARHGAP14, KIAA0411, WRP
12 results:
1. Concurrent-Adjuvant Chemoradiation Therapy for Stage III-IVB Nasopharyngeal Carcinoma-Exploration for Achieving Optimal 10-Year Therapeutic Ratio.
Ng WT; Tung SY; Lee V; Ngan RKC; Choi HCW; Chan LLK; Leung TW; Siu LL; Lu TX; Tan T; Tan EH; Sze HCK; Ng AWY; Yiu HHY; O'Sullivan B; Chappell R; Lee AWM
Int J Radiat Oncol Biol Phys; 2018 Aug; 101(5):1078-1086. PubMed ID: 29885997
[TBL] [Abstract] [Full Text] [Related]
2. A multicenter, phase 3, randomized trial of concurrent chemoradiotherapy plus adjuvant chemotherapy versus radiotherapy alone in patients with regionally advanced nasopharyngeal carcinoma: 10-year outcomes for efficacy and toxicity.
Lee AWM; Tung SY; Ng WT; Lee V; Ngan RKC; Choi HCW; Chan LLK; Siu LL; Ng AWY; Leung TW; Yiu HHY; O'Sullivan B; Chappell R
Cancer; 2017 Nov; 123(21):4147-4157. PubMed ID: 28662313
[TBL] [Abstract] [Full Text] [Related]
3. Exploratory Factor Analysis of NRG Oncology's University of Washington Quality of Life Questionnaire-RTOG Modification.
Pugh SL; Wyatt G; Wong RK; Sagar SM; Yueh B; Singh AK; Yao M; Nguyen-Tan PF; Yom SS; Cardinale FS; Sultanem K; Hodson DI; Krempl GA; Chavez A; Yeh AM; Bruner DW
J Pain Symptom Manage; 2017 Jan; 53(1):139-145.e2. PubMed ID: 27899312
[TBL] [Abstract] [Full Text] [Related]
4. Surgery alone versus chemoradiotherapy followed by surgery for stage I and II esophageal cancer: final analysis of randomized controlled phase III trial FFCD 9901.
Mariette C; Dahan L; Mornex F; Maillard E; Thomas PA; Meunier B; Boige V; Pezet D; Robb WB; Le Brun-Ly V; Bosset JF; Mabrut JY; Triboulet JP; Bedenne L; Seitz JF
J Clin Oncol; 2014 Aug; 32(23):2416-22. PubMed ID: 24982463
[TBL] [Abstract] [Full Text] [Related]
5. The impact of concurrent granulocyte-macrophage colony-stimulating factor on quality of life in head and neck cancer patients: results of the randomized, placebo-controlled Radiation Therapy Oncology Group 9901 trial.
Hoffman KE; Pugh SL; James JL; Scarantino C; Movsas B; Valicenti RK; Fortin A; Pollock J; Kim H; Brachman DG; Berk LB; Bruner DW; Kachnic LA
Qual Life Res; 2014 Aug; 23(6):1841-58. PubMed ID: 24492945
[TBL] [Abstract] [Full Text] [Related]
6. Cytopathology: a useful technique for diagnosing oral lesions?: a systematic literature review.
Dolens Eda S; Nakai FV; Santos Parizi JL; Alborghetti Nai G
Diagn Cytopathol; 2013 Jun; 41(6):505-14. PubMed ID: 22645047
[TBL] [Abstract] [Full Text] [Related]
7. Evidence based and new developments in re-irradiation for recurrent or second primary head and neck cancers.
Mouttet-Audouard R; Gras L; Comet B; Lartigau E
Curr Opin Otolaryngol Head Neck Surg; 2012 Apr; 20(2):137-41. PubMed ID: 22249172
[TBL] [Abstract] [Full Text] [Related]
8. [Reirradiation for recurrent or second primary head and neck cancers].
Mouttet-Audouard R; Gras L; Comet B; Lartigau E
Bull Cancer; 2011 Dec; 98(12):1477-88. PubMed ID: 22157636
[TBL] [Abstract] [Full Text] [Related]
9. Factors contributing to the efficacy of concurrent-adjuvant chemotherapy for locoregionally advanced nasopharyngeal carcinoma: combined analyses of NPC-9901 and NPC-9902 Trials.
Lee AW; Tung SY; Ngan RK; Chappell R; Chua DT; Lu TX; Siu L; Tan T; Chan LK; Ng WT; Leung TW; Fu YT; Au GK; Zhao C; O'Sullivan B; Tan EH; Lau WH
Eur J Cancer; 2011 Mar; 47(5):656-66. PubMed ID: 21112774
[TBL] [Abstract] [Full Text] [Related]
10. The impact of concurrent granulocyte macrophage-colony stimulating factor on radiation-induced mucositis in head and neck cancer patients: a double-blind placebo-controlled prospective phase III study by Radiation Therapy Oncology Group 9901.
Ryu JK; Swann S; LeVeque F; Scarantino CW; Johnson D; Chen A; Fortin A; Pollock J; Kim H; Ang KK
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):643-50. PubMed ID: 17293228
[TBL] [Abstract] [Full Text] [Related]
11. Preliminary results of a randomized study on therapeutic gain by concurrent chemotherapy for regionally-advanced nasopharyngeal carcinoma: NPC-9901 Trial by the Hong Kong Nasopharyngeal cancer Study Group.
Lee AW; Lau WH; Tung SY; Chua DT; Chappell R; Xu L; Siu L; Sze WM; Leung TW; Sham JS; Ngan RK; Law SC; Yau TK; Au JS; O'Sullivan B; Pang ES; O SK; Au GK; Lau JT;
J Clin Oncol; 2005 Oct; 23(28):6966-75. PubMed ID: 16192584
[TBL] [Abstract] [Full Text] [Related]
12. Full dose reirradiation combined with chemotherapy after salvage surgery in head and neck carcinoma.
De Crevoisier R; Domenge C; Wibault P; Koscielny S; Lusinchi A; Janot F; Bobin S; Luboinski B; Eschwege F; Bourhis J
Cancer; 2001 Jun; 91(11):2071-6. PubMed ID: 11391587
[TBL] [Abstract] [Full Text] [Related]
